IGM Biosciences, Inc. Net Income
IGM Biosciences, Inc. reported Net Income of $97.58 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Income Statement
us-gaap:NetIncomeLoss · last filed 2025-07-31
- IGM Biosciences, Inc. net income (loss) attributable to parent for the quarter ending 2025-06-30 was $97.58M.
- IGM Biosciences, Inc. net income (loss) attributable to parent for the quarter ending 2025-03-31 was -$52.89M.
- IGM Biosciences, Inc. net income (loss) attributable to parent for the quarter ending 2024-12-31 was -$36.65M.
- IGM Biosciences, Inc. net income (loss) attributable to parent for the quarter ending 2024-09-30 was -$61.43M.
- IGM Biosciences, Inc. net income (loss) attributable to parent for fiscal 2024 was -$195.79M.
- IGM Biosciences, Inc. net income (loss) attributable to parent for fiscal 2023 was -$246.42M.
- IGM Biosciences, Inc. net income (loss) attributable to parent for fiscal 2022 was -$221.10M.
- IGM Biosciences, Inc. net income (loss) attributable to parent for fiscal 2021 was -$165.16M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2025-06-30 | $97.58M 10-Q · filed 2025-07-31 | $44.69M 10-Q · filed 2025-07-31 | $8.04M derived: sum of 3 quarters · filed 2025-07-31 | -$53.38M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | -$52.89M 10-Q · filed 2025-07-31 | -$89.54M derived: sum of 2 quarters · filed 2025-07-31 | -$150.97M derived: sum of 3 quarters · filed 2025-07-31 | -$198.87M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-12-31 | -$36.65M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$98.08M derived: sum of 2 quarters · filed 2025-03-06 | -$145.98M derived: sum of 3 quarters · filed 2025-07-31 | -$195.79M 10-K · filed 2025-03-06 |
| 2024-09-30 | -$61.43M 10-Q · filed 2024-11-08 | -$109.33M derived: sum of 2 quarters · filed 2025-07-31 | -$159.15M 10-Q · filed 2024-11-08 | -$219.84M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-06-30 | -$47.90M 10-Q · filed 2025-07-31 | -$97.72M 10-Q · filed 2025-07-31 | -$158.41M derived: sum of 3 quarters · filed 2025-07-31 | -$220.40M derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$49.82M 10-Q · filed 2025-07-31 | -$110.51M derived: sum of 2 quarters · filed 2025-07-31 | -$172.50M derived: sum of 3 quarters · filed 2025-07-31 | -$236.92M derived: sum of 4 quarters · filed 2025-07-31 |
| 2023-12-31 | -$60.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$122.68M derived: sum of 2 quarters · filed 2025-03-06 | -$187.11M derived: sum of 3 quarters · filed 2025-03-06 | -$246.42M 10-K · filed 2025-03-06 |
| 2023-09-30 | -$61.99M 10-Q · filed 2024-11-08 | -$126.41M derived: sum of 2 quarters · filed 2024-11-08 | -$185.72M 10-Q · filed 2024-11-08 | -$238.30M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-06-30 | -$64.42M 10-Q · filed 2024-11-08 | -$123.73M 10-Q · filed 2024-08-14 | -$176.31M derived: sum of 3 quarters · filed 2025-03-06 | -$234.34M derived: sum of 4 quarters · filed 2025-03-06 |
| 2023-03-31 | -$59.31M 10-Q · filed 2024-11-08 | -$111.89M derived: sum of 2 quarters · filed 2025-03-06 | -$169.92M derived: sum of 3 quarters · filed 2025-03-06 | -$228.52M derived: sum of 4 quarters · filed 2025-03-06 |
| 2022-12-31 | -$52.58M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$110.61M derived: sum of 2 quarters · filed 2025-03-06 | -$169.21M derived: sum of 3 quarters · filed 2025-03-06 | -$221.10M 10-K · filed 2025-03-06 |
| 2022-09-30 | -$58.04M 10-Q · filed 2023-11-13 | -$116.63M derived: sum of 2 quarters · filed 2023-11-13 | -$168.53M 10-Q · filed 2023-11-13 | -$219.17M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | -$58.59M 10-Q · filed 2023-11-13 | -$110.49M 10-Q · filed 2023-08-03 | -$161.13M derived: sum of 3 quarters · filed 2024-03-07 | -$205.29M derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | -$51.89M 10-Q · filed 2023-11-13 | -$102.54M derived: sum of 2 quarters · filed 2024-03-07 | -$146.70M derived: sum of 3 quarters · filed 2024-03-07 | -$185.41M derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | -$50.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$94.81M derived: sum of 2 quarters · filed 2024-03-07 | -$133.52M derived: sum of 3 quarters · filed 2024-03-07 | -$165.16M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$44.16M 10-Q · filed 2022-11-03 | -$82.88M derived: sum of 2 quarters · filed 2022-11-03 | -$114.52M 10-Q · filed 2022-11-03 | -$139.14M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-06-30 | -$38.71M 10-Q · filed 2022-11-03 | -$70.36M 10-Q · filed 2022-08-08 | -$94.98M derived: sum of 3 quarters · filed 2022-11-03 | -$115.25M derived: sum of 4 quarters · filed 2022-11-03 |
| 2021-03-31 | -$31.64M 10-Q · filed 2022-11-03 | -$56.27M derived: sum of 2 quarters · filed 2022-11-03 | -$76.54M derived: sum of 3 quarters · filed 2022-11-03 | -$95.38M derived: sum of 4 quarters · filed 2022-11-03 |
| 2020-12-31 | -$24.62M 10-K · filed 2021-03-30 | -$44.89M derived: sum of 2 quarters · filed 2021-11-04 | -$63.73M derived: sum of 3 quarters · filed 2021-11-04 | -$81.36M 10-K · filed 2023-03-30 |
| 2020-09-30 | -$20.27M 10-Q · filed 2021-11-04 | -$39.11M derived: sum of 2 quarters · filed 2021-11-04 | -$56.73M 10-Q · filed 2021-11-04 | -$71.55M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | -$18.84M 10-Q · filed 2021-11-04 | -$36.46M 10-Q · filed 2021-08-09 | -$51.28M derived: sum of 3 quarters · filed 2021-11-04 | -$61.45M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-03-31 | -$17.62M 10-Q · filed 2021-11-04 | -$32.44M derived: sum of 2 quarters · filed 2021-11-04 | -$42.61M derived: sum of 3 quarters · filed 2021-11-04 | -$53.29M derived: sum of 4 quarters · filed 2021-11-04 |
| 2019-12-31 | -$14.81M 10-K · filed 2021-03-30 | -$24.99M derived: sum of 2 quarters · filed 2021-03-30 | -$35.66M derived: sum of 3 quarters · filed 2021-03-30 | -$43.13M 10-K · filed 2022-03-29 |
| 2019-09-30 | -$10.17M 10-K · filed 2021-03-30 | -$20.85M derived: sum of 2 quarters · filed 2021-03-30 | -$28.32M 10-Q · filed 2020-11-05 | -$37.37M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-06-30 | -$10.68M 10-K · filed 2021-03-30 | -$18.15M 10-Q · filed 2020-08-06 | -$27.20M derived: sum of 3 quarters · filed 2021-03-30 | -$33.72M derived: sum of 4 quarters · filed 2021-03-30 |
| 2019-03-31 | -$7.47M 10-K · filed 2021-03-30 | -$16.52M derived: sum of 2 quarters · filed 2021-03-30 | -$23.04M derived: sum of 3 quarters · filed 2021-03-30 | -$27.25M derived: sum of 4 quarters · filed 2021-03-30 |
| 2018-12-31 | -$9.05M 10-K · filed 2020-03-26 | -$15.57M derived: sum of 2 quarters · filed 2020-03-26 | -$19.79M derived: sum of 3 quarters · filed 2020-03-26 | -$22.71M 10-K · filed 2021-03-30 |
| 2018-09-30 | -$6.52M 10-K · filed 2020-03-26 | -$10.73M derived: sum of 2 quarters · filed 2020-03-26 | -$13.66M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$4.21M 10-K · filed 2020-03-26 | -$7.14M derived: sum of 2 quarters · filed 2020-03-26 | ||
| 2018-03-31 | -$2.93M 10-K · filed 2020-03-26 | |||
| 2017-12-31 | -$11.05M 10-K · filed 2020-03-26 |